Charles Darwin University

CDU eSpace
Institutional Repository

CDU Staff and Student only

In Vivo and In Vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia

Seswantoro H., Russell, Barry, Ratcliff, A., Prasetyorini, B., Chalfein, Ferryanto, Marfurt, Jutta, Kenangalem, Enny, Wuwung, M., Piera, Kim A., Ebsworth, E. P., Anstey, Nicholas M., Tjitra, Emiliana and Price, Ric N. (2011). In Vivo and In Vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia. Antimicrobial Agents and Chemotherapy,55(1):197-202.

Document type: Journal Article
Attached Files (Some files may be inaccessible until you login with your CDU eSpace credentials)
Name Description MIMEType Size Downloads
Download this reading Ratcliff_37834.pdf Published version application/pdf 490.01KB 242
Reading the attached file works best in Firefox, Chrome and IE 9 or later.

IRMA ID bsmithxPUB23
Title In Vivo and In Vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia
Author Seswantoro H.
Russell, Barry
Ratcliff, A.
Prasetyorini, B.
Chalfein, Ferryanto
Marfurt, Jutta
Kenangalem, Enny
Wuwung, M.
Piera, Kim A.
Ebsworth, E. P.
Anstey, Nicholas M.
Tjitra, Emiliana
Price, Ric N.
Journal Name Antimicrobial Agents and Chemotherapy
Publication Date 2011
Volume Number 55
Issue Number 1
ISSN 0066-4804   (check CDU catalogue open catalogue search in new window)
Start Page 197
End Page 202
Total Pages 6
Place of Publication Washington, United States
HERDC Category C1 - Journal Article (DIISR)
Abstract Reports of potential drug-resistant strains of Plasmodium malariae in western Indonesia raise concerns that chloroquine resistance may be emerging in P. malariae and P. ovale. In order to assess this, in vivo and in vitro efficacy studies were conducted in patients with monoinfection in Papua, Indonesia. Consecutive patients with uncomplicated malaria due to P. ovale or P. malariae were enrolled in a prospective clinical trial, provided with supervised chloroquine treatment, and followed for 28 days. Blood from patients with P. malariae or P. ovale parasitemia greater than 1,000 per microliter underwent in vitro antimalarial drug susceptibility testing using a modified schizont maturation assay. Of the 57 evaluable patients in the clinical study (P. malariae, n = 46; P. ovale, n = 11), none had recurrence with the same species during follow-up. The mean parasite reduction ratio at 48 h was 86 (95% confidence interval [CI], 57 to 114) for P. malariae and 150 (95% CI, 54 to 245) for P. ovale (P = 0.18). One patient infected with P. malariae, with 93% of parasites at the trophozoite stage, was still parasitemic on day 4. In vitro drug susceptibility assays were carried out successfully for 40 isolates (34 infected with P. malariae and 6 with P. ovale). The P. malariae infections at trophozoite stages had significantly higher chloroquine 50% effective concentrations (EC50s) (median, 127.9 nM [range, 7.9 to 2,980]) than those initially exposed at the ring stage (median, 14.0 nM [range, 3.5 to 27.0]; P = 0.01). The EC50 for chloroquine in P. ovale was also higher in an isolate initially at the trophozoite stage (23.2 nM) than in the three isolates predominantly at ring stage (7.8 nM). Chloroquine retains adequate efficacy against P. ovale and P. malariae, but its marked stage specificity of action may account for reports of delayed parasite clearance times.

DOI   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)

© copyright

Every reasonable effort has been made to ensure that permission has been obtained for items included in CDU eSpace. If you believe that your rights have been infringed by this repository, please contact

Version Filter Type
Access Statistics: 213 Abstract Views, 242 File Downloads  -  Detailed Statistics
Created: Fri, 17 Jan 2014, 00:56:56 CST